PL2170860T3 - Pochodne benzimidazolu - Google Patents

Pochodne benzimidazolu

Info

Publication number: PL2170860T3
Authority: PL; Poland
Prior art keywords: benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2007-06-29

Application number

PL08762901T

Other languages

English (en)

Inventor

Christopher Scott Jones

GRECA Susan LA

Qifang Li

Michael John Munchhof

Lawrence Alan Reiter

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-29

Filing date

2008-06-16

Publication date

2017-05-31

2008-06-16 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2017-05-31 Publication of PL2170860T3 publication Critical patent/PL2170860T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL08762901T 2007-06-29 2008-06-16 Pochodne benzimidazolu PL2170860T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94728707P	2007-06-29	2007-06-29
US4164508P	2008-04-02	2008-04-02

Publications (1)

Publication Number	Publication Date
PL2170860T3 true PL2170860T3 (pl)	2017-05-31

Family

ID=40161351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08762901T PL2170860T3 (pl)	2007-06-29	2008-06-16	Pochodne benzimidazolu

Country Status (45)

Country	Link
US (2)	US8148401B2 (pl)
EP (1)	EP2170860B9 (pl)
JP (2)	JP4567099B2 (pl)
KR (1)	KR101143246B1 (pl)
CN (1)	CN101687841B (pl)
AP (1)	AP2377A (pl)
AR (1)	AR067346A1 (pl)
AU (1)	AU2008272641B2 (pl)
BR (1)	BRPI0813412B8 (pl)
CA (1)	CA2690953C (pl)
CL (1)	CL2008001922A1 (pl)
CO (1)	CO6160232A2 (pl)
CR (1)	CR11150A (pl)
CU (1)	CU23847B1 (pl)
CY (2)	CY1118650T1 (pl)
DK (1)	DK2170860T5 (pl)
DO (1)	DOP2009000278A (pl)
EA (1)	EA016888B1 (pl)
EC (1)	ECSP099803A (pl)
ES (1)	ES2609258T3 (pl)
FR (1)	FR20C1038I2 (pl)
GE (1)	GEP20125702B (pl)
GT (1)	GT200900328A (pl)
HN (1)	HN2008000974A (pl)
HR (1)	HRP20161562T2 (pl)
HU (2)	HUE030052T4 (pl)
IL (1)	IL202420A (pl)
LT (2)	LT2170860T (pl)
MA (1)	MA31466B1 (pl)
ME (1)	ME00962B (pl)
MY (1)	MY148636A (pl)
NI (1)	NI200900219A (pl)
NL (1)	NL301057I2 (pl)
NO (1)	NO2020027I1 (pl)
NZ (1)	NZ581889A (pl)
PA (1)	PA8785401A1 (pl)
PE (2)	PE20121010A1 (pl)
PL (1)	PL2170860T3 (pl)
PT (1)	PT2170860T (pl)
RS (1)	RS55395B9 (pl)
SI (1)	SI2170860T1 (pl)
TN (1)	TN2009000544A1 (pl)
TW (1)	TWI371451B (pl)
UY (1)	UY31164A1 (pl)
WO (1)	WO2009004427A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME00962B (me)	2007-06-29	2012-06-20	Pfizer	Benzimidazolski derivati
ES2620027T3 (es)	2008-09-03	2017-06-27	Biomarin Pharmaceutical Inc.	Composiciones que incluyen derivados del ácido 6-aminohexanoico como inhibidores de HDAC
MX2011013294A (es) *	2009-06-11	2012-01-12	Siena Biotech Spa	Antagonistas de la trayectoria de hedgehog y aplicaciones terapeuticas de los mismos.
NZ598749A (en)	2009-08-26	2013-01-25	Takeda Pharmaceutical	Fused heterocyclic ring derivative and use thereof
US8628554B2 (en)	2010-06-13	2014-01-14	Virender K. Sharma	Intragastric device for treating obesity
US9526648B2 (en)	2010-06-13	2016-12-27	Synerz Medical, Inc.	Intragastric device for treating obesity
US10010439B2 (en)	2010-06-13	2018-07-03	Synerz Medical, Inc.	Intragastric device for treating obesity
US10420665B2 (en)	2010-06-13	2019-09-24	W. L. Gore & Associates, Inc.	Intragastric device for treating obesity
CA2813162C (en)	2010-10-20	2015-06-16	Pfizer Inc.	Pyridine-2- derivatives as smoothened receptor modulators
JP5452459B2 (ja)	2010-12-16	2014-03-26	株式会社Ｎｔｔドコモ	ホーム基地局及びハンドオーバ方法
US8957066B2 (en)	2011-02-28	2015-02-17	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US9540395B2 (en)	2011-02-28	2017-01-10	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
US10059723B2 (en)	2011-02-28	2018-08-28	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
WO2012122370A2 (en) *	2011-03-08	2012-09-13	Eutropics Pharmaceuticals, Inc.	Compositions and methods useful for treating diseases
FR2980477B1 (fr)	2011-09-23	2013-10-18	Centre Nat Rech Scient	Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
JP6163156B2 (ja) *	2011-09-26	2017-07-12	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	リゾホスファチジン酸（ｌｐａ）受容体アンタゴニストとしてのベンジルピペリジン化合物
IN2014DN11205A (pl)	2012-06-20	2015-10-02	Eutropics Pharmaceuticals Inc
EP2922544B1 (en)	2012-11-21	2018-08-01	Eutropics Pharmaceuticals, Inc.	Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
KR20150132345A (ko)	2013-03-15	2015-11-25	바이오마린 파머수티컬 인크.	Hdac 저해제
US10435364B2 (en)	2013-04-17	2019-10-08	Albert Ludwigs Universität Freiburg	Compounds for use as bromodomain inhibitors
WO2015017788A1 (en)	2013-08-01	2015-02-05	Eutropics Pharmaceuticals, Inc.	Method for predicting cancer sensitivity
GB2519344A (en) *	2013-10-18	2015-04-22	Redx Pharma Ltd	Compounds
AU2014342269B2 (en)	2013-10-30	2020-02-27	Eutropics Pharmaceuticals, Inc.	Methods for determining chemosensitivity and chemotoxicity
BR112017021075B1 (pt) *	2015-04-24	2021-08-03	Pfizer Inc.	Forma cristalina de maleato de 1-((2r,4r)-2-(1h- benzo[d]imidazol-2-il)-1-metilpiperidin-4-il)-3-(4- cianofenil)ureia e composição farmacêutica
US10779980B2 (en)	2016-04-27	2020-09-22	Synerz Medical, Inc.	Intragastric device for treating obesity
JP2020164722A (ja) *	2019-03-29	2020-10-08	デクセリアルズ株式会社	接着剤組成物
US20230107634A1 (en)	2020-01-28	2023-04-06	Teva Pharmaceuticals International Gmbh	Processes for the preparation of glasdegib and salt thereof and solid state forms of glasdegib maleate and process for preparation thereof
CN113248475B (zh) *	2020-02-11	2023-03-17	中国科学院上海药物研究所	一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
EP4126237B1 (en)	2020-03-26	2024-04-10	LEK Pharmaceuticals d.d.	Dimaleate form of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
CN115997122A (zh)	2020-06-26	2023-04-21	拉夸里亚创药株式会社	类维生素a与癌治疗剂的组合疗法有效的癌患者的选择方法、及类维生素a与癌治疗剂的组合药物
WO2023002362A1 (en)	2021-07-22	2023-01-26	Pfizer Inc.	Treatment of hematological malignancy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA007339B1 (ru) *	2001-07-27	2006-08-25	Кьюэрис, Инк.	Медиаторы путей передачи сигналов генами hedgehog, содержащие их композиции и способы применения указанных веществ
CA2473892C (en) *	2001-12-04	2010-09-21	Actelion Pharmaceuticals Ltd	Novel quinoline derivatives
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
US7582761B2 (en) *	2002-10-17	2009-09-01	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
WO2005042495A1 (en)	2003-10-21	2005-05-12	Imclone Systems Incorporated	(benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity
NZ547109A (en)	2003-10-28	2010-03-26	Vertex Pharma	Benzimidazoles useful as modulators of ion channels
CA2587489C (en) *	2004-11-03	2013-12-31	Curis, Inc.	Mediators of hedgehog signaling pathways, compositions and uses related thereto
DE102005012875B4 (de) *	2005-03-19	2006-11-16	Sanofi-Aventis Deutschland Gmbh	Verwendung von Amino substituierten 8-N-Benzimidazolen
WO2006124780A2 (en) *	2005-05-12	2006-11-23	Kalypsys, Inc.	Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase
WO2008064830A1 (en)	2006-11-27	2008-06-05	Ucb Pharma, S.A.	Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses
JP2010513263A (ja)	2006-12-15	2010-04-30	ファイザー・プロダクツ・インク	ベンズイミダゾール誘導体
ME00962B (me)	2007-06-29	2012-06-20	Pfizer	Benzimidazolski derivati
EP2303275A4 (en)	2008-06-17	2012-05-09	Univ Duke	STANDARD RECEPTOR MODULATORS
EP2328871B1 (en)	2008-08-25	2020-04-01	Novartis AG	Hedgehog pathway modulators

2008
- 2008-06-16 ME MEP-2009-349A patent/ME00962B/me unknown
- 2008-06-16 ES ES08762901.0T patent/ES2609258T3/es active Active
- 2008-06-16 KR KR1020107001991A patent/KR101143246B1/ko active Active
- 2008-06-16 GE GEAP200811622A patent/GEP20125702B/en unknown
- 2008-06-16 BR BRPI0813412A patent/BRPI0813412B8/pt active IP Right Grant
- 2008-06-16 PL PL08762901T patent/PL2170860T3/pl unknown
- 2008-06-16 AU AU2008272641A patent/AU2008272641B2/en active Active
- 2008-06-16 WO PCT/IB2008/001575 patent/WO2009004427A2/en not_active Ceased
- 2008-06-16 MY MYPI20095266A patent/MY148636A/en unknown
- 2008-06-16 HU HUE08762901A patent/HUE030052T4/en unknown
- 2008-06-16 AP AP2009005089A patent/AP2377A/xx active
- 2008-06-16 SI SI200831707A patent/SI2170860T1/sl unknown
- 2008-06-16 CN CN200880022602XA patent/CN101687841B/zh active Active
- 2008-06-16 EA EA200971104A patent/EA016888B1/ru unknown
- 2008-06-16 JP JP2010514162A patent/JP4567099B2/ja active Active
- 2008-06-16 RS RS20161132A patent/RS55395B9/sr unknown
- 2008-06-16 CA CA2690953A patent/CA2690953C/en active Active
- 2008-06-16 HR HRP20161562TT patent/HRP20161562T2/hr unknown
- 2008-06-16 DK DK08762901.0T patent/DK2170860T5/en active
- 2008-06-16 EP EP08762901.0A patent/EP2170860B9/en active Active
- 2008-06-16 LT LTEP08762901.0T patent/LT2170860T/lt unknown
- 2008-06-16 PT PT87629010T patent/PT2170860T/pt unknown
- 2008-06-16 NZ NZ581889A patent/NZ581889A/en unknown
- 2008-06-19 US US12/142,119 patent/US8148401B2/en active Active
- 2008-06-19 PA PA20088785401A patent/PA8785401A1/es unknown
- 2008-06-20 UY UY31164A patent/UY31164A1/es active IP Right Grant
- 2008-06-25 HN HN2008000974A patent/HN2008000974A/es unknown
- 2008-06-27 TW TW097124392A patent/TWI371451B/zh active
- 2008-06-27 PE PE2012000473A patent/PE20121010A1/es active IP Right Grant
- 2008-06-27 CL CL2008001922A patent/CL2008001922A1/es unknown
- 2008-06-27 PE PE2008001105A patent/PE20090772A1/es active IP Right Grant
- 2008-06-27 AR ARP080102792A patent/AR067346A1/es active IP Right Grant
2009
- 2009-11-30 IL IL202420A patent/IL202420A/en active IP Right Grant
- 2009-12-07 CR CR11150A patent/CR11150A/es unknown
- 2009-12-08 DO DO2009000278A patent/DOP2009000278A/es unknown
- 2009-12-14 EC EC2009009803A patent/ECSP099803A/es unknown
- 2009-12-18 NI NI200900219A patent/NI200900219A/es unknown
- 2009-12-21 GT GT200900328A patent/GT200900328A/es unknown
- 2009-12-21 CU CU2009000225A patent/CU23847B1/es active IP Right Grant
- 2009-12-23 CO CO09147462A patent/CO6160232A2/es unknown
- 2009-12-25 TN TNP2009000544A patent/TN2009000544A1/fr unknown
- 2009-12-29 MA MA32454A patent/MA31466B1/fr unknown
2010
- 2010-08-04 JP JP2010175465A patent/JP2010280693A/ja active Pending
2012
- 2012-02-24 US US13/404,169 patent/US8431597B2/en active Active
2016
- 2016-12-14 CY CY20161101293T patent/CY1118650T1/el unknown
2020
- 2020-07-15 NL NL301057C patent/NL301057I2/nl unknown
- 2020-08-11 NO NO2020027C patent/NO2020027I1/no unknown
- 2020-08-12 CY CY2020028C patent/CY2020028I2/el unknown
- 2020-08-13 HU HUS2000031C patent/HUS2000031I1/hu unknown
- 2020-08-20 FR FR20C1038C patent/FR20C1038I2/fr active Active
- 2020-08-26 LT LTPA2020528C patent/LTC2170860I2/lt unknown

Also Published As

Publication number	Publication date
CY2020028I1 (el)	2020-11-25
CY2020028I2 (el)	2020-11-25
CY1118650T1 (el)	2017-07-12
MA31466B1 (fr)	2010-06-01
NO2020027I1 (no)	2020-08-11
EP2170860B1 (en)	2016-11-02
IL202420A0 (en)	2010-06-30
AR067346A1 (es)	2009-10-07
ES2609258T3 (es)	2017-04-19
PE20121010A1 (es)	2012-08-06
KR20100028120A (ko)	2010-03-11
BRPI0813412A2 (pt)	2014-12-30
MY148636A (en)	2013-05-15
FR20C1038I2 (fr)	2021-08-13
PT2170860T (pt)	2017-01-04
WO2009004427A3 (en)	2009-06-04
CN101687841B (zh)	2013-07-10
KR101143246B1 (ko)	2012-05-18
HUE030052T4 (en)	2017-06-28
CR11150A (es)	2010-02-08
GEP20125702B (en)	2012-12-10
WO2009004427A2 (en)	2009-01-08
JP4567099B2 (ja)	2010-10-20
EP2170860B9 (en)	2017-02-22
HRP20161562T1 (hr)	2016-12-30
LTPA2020528I1 (lt)	2020-09-25
HUE030052T2 (hu)	2017-04-28
NI200900219A (es)	2010-03-11
PE20090772A1 (es)	2009-06-24
HRP20161562T2 (hr)	2017-04-21
FR20C1038I1 (pl)	2020-10-02
AP2377A (en)	2012-03-07
PA8785401A1 (es)	2009-01-23
BRPI0813412B8 (pt)	2021-05-25
DK2170860T5 (en)	2017-03-20
HK1139658A1 (en)	2010-09-24
NZ581889A (en)	2011-05-27
TW200911792A (en)	2009-03-16
LTC2170860I2 (lt)	2022-03-10
HUS2000031I1 (hu)	2020-09-28
EA200971104A1 (ru)	2010-06-30
US20120157495A1 (en)	2012-06-21
HN2008000974A (es)	2011-01-24
IL202420A (en)	2014-05-28
JP2010531869A (ja)	2010-09-30
AU2008272641A1 (en)	2009-01-08
US20090005416A1 (en)	2009-01-01
CU23847B1 (es)	2012-10-15
ECSP099803A (es)	2010-01-29
US8148401B2 (en)	2012-04-03
GT200900328A (es)	2011-08-29
CL2008001922A1 (es)	2009-01-02
CN101687841A (zh)	2010-03-31
RS55395B1 (sr)	2017-04-28
NL301057I1 (nl)	2020-07-22
US8431597B2 (en)	2013-04-30
EP2170860A2 (en)	2010-04-07
RS55395B9 (sr)	2020-01-31
DK2170860T3 (en)	2017-01-09
JP2010280693A (ja)	2010-12-16
CO6160232A2 (es)	2010-05-20
ME00962B (me)	2012-06-20
AP2009005089A0 (en)	2009-12-31
CA2690953C (en)	2012-10-02
NL301057I2 (nl)	2020-09-10
CA2690953A1 (en)	2009-01-08
TN2009000544A1 (fr)	2011-03-31
DOP2009000278A (es)	2009-12-31
BRPI0813412B1 (pt)	2020-01-21
TWI371451B (en)	2012-09-01
EA016888B1 (ru)	2012-08-30
SI2170860T1 (sl)	2017-01-31
CU20090225A7 (es)	2012-02-15
UY31164A1 (es)	2009-01-30
LT2170860T (lt)	2017-01-10
AU2008272641B2 (en)	2013-08-29

Publication	Publication Date	Title
HUS2000031I1 (hu)	2020-09-28	Benzimidazol-származékok
ZA201003631B (en)	2013-10-30	Isoxazolo-pyridine derivatives
IL205753A0 (en)	2010-11-30	Isoxazolo-pyridazine derivatives
IL202020A0 (en)	2010-06-16	Spiroindolinone derivatives
ZA201000431B (en)	2011-12-28	Indazolamide derivatives
ZA201001058B (en)	2010-11-24	Quinazolinamide derivatives
IL205755A0 (en)	2010-11-30	Isoxazolo-pyrazine derivatives
IL204683A0 (en)	2010-11-30	Imidazole derivatives
IL200618A0 (en)	2010-05-17	Aza-pyridopyrimidinone derivatives
TWI348908B (en)	2011-09-21	Imidazolidinone derivatives
IL209733A0 (en)	2011-02-28	New benzimidazole derivatives
IL202667A0 (en)	2010-06-30	Isoxazole-imidazole derivatives
IL193475A0 (en)	2009-05-04	Benzimidazole derivatives
PL2245028T3 (pl)	2012-07-31	Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2133347A4 (en)	2010-03-17	1-BIARYLAZETIDINONDERIVATE
EP2172454A4 (en)	2010-12-08	benzimidazole derivative
IL202463A0 (en)	2010-06-30	Sulfonyl-quinoline derivatives
IL202159A0 (en)	2010-06-16	Piperidine-amide derivatives
IL211806A0 (en)	2011-06-30	New benzimidazole derivatives
ZA201002218B (en)	2010-12-29	Thiadiazinone derivatives
ZA200908626B (en)	2010-08-25	Benzimidazole Derivatives
GB0722377D0 (en)	2007-12-27	Benzimidazole compounds
ZA201000311B (en)	2010-10-27	Sulfonyl-quinoline derivatives
AP2009005065A0 (en)	2009-12-31	Sulfonyl-quinoline derivatives
GB0702266D0 (en)	2007-03-14	7-Azaindoe derivatives